| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.67M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -27.56M | $ -19.05M | $ -17.53M | $ -13.88M | $ -14.93M |
| EBITDA | $ -25.89M | $ -17.76M | $ -17.04M | $ -13.72M | $ -15.76M |
| Net Income | $ -28.24M | $ -18.82M | $ -17.47M | $ -13.88M | $ -18.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.94M | $ 13.10M | $ 9.23M | $ 3.80M | $ 9.08M |
| Total Assets | $ 14.83M | $ 18.73M | $ 13.81M | $ 7.25M | $ 9.85M |
| Total Debt | $ 393.00K | $ 816.00K | $ 1.19M | $ 1.55M | $ 184.81K |
| Net Debt | $ -6.55M | $ -12.28M | $ -8.04M | $ -2.25M | $ -8.89M |
| Total Liabilities | $ 1.87M | $ 1.66M | $ 2.27M | $ 2.17M | $ 1.01M |
| Stockholders' Equity | $ 12.96M | $ 17.08M | $ 11.54M | $ 5.08M | $ 8.84M |
| Cash Flow | |||||
| Free Cash Flow | $ -27.68M | $ -18.21M | $ -15.65M | $ -12.65M | $ -10.31M |
| Operating Cash Flow | $ -23.75M | $ -15.72M | $ -13.95M | $ -11.01M | $ -10.26M |
| Investing Cash Flow | $ -3.93M | $ -2.49M | $ -1.70M | $ -1.64M | $ -54.76K |
| Financing Cash Flow | $ 21.53M | $ 22.08M | $ 21.09M | $ 7.37M | $ 17.92M |
Modular Medical Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.